Dianthus Therapeutics (DNTH) Asset Utilization Ratio (2022 - 2025)

Dianthus Therapeutics' quarterly Asset Utilization Ratio came in at 0.01 in Q3 2025, down 53.26% year-on-year from 0.01 in Q3 2024, and down 52.44% quarter-over-quarter from 0.01 in Q2 2025.

Dianthus Therapeutics has reported Asset Utilization Ratio for 4 years, with the latest figure at 0.01 in Q3 2025.

  • For the quarter ending Q3 2025, Asset Utilization Ratio fell 53.26% year-over-year to 0.01; the trailing twelve-month figure through Sep 2025 stood at 0.01 (down 53.26% YoY), and the FY2024 full-year result was 0.02, up 4.66% from the prior year.
  • Asset Utilization Ratio for Q3 2025 stood at 0.01, down from 0.01 in the prior quarter.
  • The five-year high for Asset Utilization Ratio was 0.05 in Q2 2023, with the low at 0.01 in Q3 2025.
  • Average Asset Utilization Ratio over 4 years is 0.02, with a median of 0.02 recorded in 2023.
  • Year-over-year, Asset Utilization Ratio jumped 277.01% in 2023 and sank 76.98% in 2024.
  • Tracing DNTH's Asset Utilization Ratio over 4 years: stood at 0.02 in 2022, then retreated by 20.08% to 0.02 in 2023, then rose by 13.62% to 0.02 in 2024, then tumbled by 59.73% to 0.01 in 2025.
  • The last three Asset Utilization Ratio figures came in at 0.01 (Q3 2025), 0.01 (Q2 2025), and 0.02 (Q1 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Asset Util. (Qtr)
1 Quantum Biopharma 1,216,509.61 Bn 1,216,509.61 Bn - -
2 Alterity Therapeutics 764,224.41 Bn 764,224.38 Bn - -
3 Legend Biotech 2,716.00 Bn 2,715.71 Bn 242.10 Mn 0.60
4 Nanobiotix 2,248.83 Bn 2,248.77 Bn - -
5 Akari Therapeutics 1,951.18 Bn 1,951.17 Bn - -
6 Vertex Pharmaceuticals 113.69 Bn 106.44 Bn 2.59 Bn 0.47
7 Evaxion A 64.16 Bn 64.14 Bn - 0.29
8 Regeneron Pharmaceuticals 63.94 Bn 55.18 Bn 3.31 Bn 0.37
9 Alnylam Pharmaceuticals 40.13 Bn 37.12 Bn 959.66 Mn 0.85
10 Dianthus Therapeutics 4.02 Bn 3.62 Bn - -

Historic Data

Download Data 🔒
DateValue
Sep 30, 2025 0.01
Jun 30, 2025 0.01
Mar 31, 2025 0.02
Dec 31, 2024 0.02
Sep 30, 2024 0.01
Jun 30, 2024 0.01
Mar 31, 2024 0.01
Dec 31, 2023 0.02
Sep 30, 2023 0.03
Jun 30, 2023 0.05
Mar 31, 2023 0.03
Dec 31, 2022 0.02
Sep 30, 2022 0.01